Pulmonary fibrolysis in a patient with idiopathic pulmonary fibrosis: improvement of clinical and radiological pattern after treatment with pirfenidone

被引:3
|
作者
Varone, Francesco [1 ]
Mastrobattista, Annelisa [1 ]
Franchi, Paola [2 ]
Viglietta, Luca [1 ]
Poletti, Venerino [3 ,4 ]
Tomassetti, Sara [3 ]
Dubini, Alessandra [5 ]
Tagliaboschi, Linda [1 ]
Calandriello, Lucio [2 ]
Farchione, Alessandra [2 ]
Larici, Anna Rita [2 ]
机构
[1] Catholic Univ, A Gemelli Hosp, Cardiothorac Dept, Pulmonol Unit, Rome, Italy
[2] Catholic Univ, A Gemelli Hosp, Inst Radiol, Dept Bioimaging & Radiol Sci, Rome, Italy
[3] GB Morgagni L Pierantoni Hosp, Dept Dis Thorax, Forli, Italy
[4] Aarhus Univ Hosp, Dept Resp Dis & Allergol, Aarhus, Denmark
[5] GB Morgagni L Pierantoni Hosp, Pathol Unit, Forli, Italy
关键词
idiopathic pulmonary fibrosis; high-resolution computed tomography; honeycombing; multidisciplinary team; pirfenidone; DIAGNOSIS;
D O I
10.1111/crj.12515
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive, fibrosing interstitial pneumonia associated with the histologic and/or radiologic pattern of usual interstitial pneumonia (UIP). Nowadays, the high-resolution computed tomography pattern of definite UIP is enough to define a diagnosis of UIP without histological proof. This is pivotal especially in elderly patients with comorbidities. Early recognition of IPF is relevant for its prognostic implication. Some pharmacological strategies have been proposing novel molecules that tend to slow lung function decline, even though without healing fibrosis. We report a case of ex-heavy smoker male with IPF showing clinical and radiological improvement after 11 months of treatment with Pirfenidone. The definite diagnosis was challenging and it was reached by a multidisciplinary approach.
引用
收藏
页码:347 / 351
页数:5
相关论文
共 50 条
  • [21] Pirfenidone treatment in idiopathic pulmonary fibrosis: nationwide Danish results
    Salih, Goran Nadir
    Shaker, Saher Burhan
    Madsen, Helle Dall
    Bendstrup, Elisabeth
    EUROPEAN CLINICAL RESPIRATORY JOURNAL, 2016, 3
  • [22] Pirfenidone Initiates a New Era in the Treatment of Idiopathic Pulmonary Fibrosis
    Selvaggio, Anna S.
    Noble, Paul W.
    ANNUAL REVIEW OF MEDICINE, VOL 67, 2016, 67 : 487 - 495
  • [23] PREDICTIVE FACTORS FOR THE EFFECT OF PIRFENIDONE IN IDIOPATHIC PULMONARY FIBROSIS
    Ichimura, Yasunori
    Tsushima, Kenji
    Matsumura, Takuma
    Yamagishi, Kazutaka
    Abe, Mitsuhiro
    Ikari, Jun
    Terada, Jiro
    Tastumi, Koichiro
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2017, 34 (04) : 290 - 299
  • [24] Clinical and radiological features of pulmonary tuberculosis in patients with idiopathic pulmonary fibrosis
    Lee, Yong-Hoon
    Cha, Seung-Ick
    Lim, Jae-Kwang
    Yoo, Seung-Soo
    Lee, Shin-Yup
    Lee, Jaehee
    Kim, Chang-Ho
    Park, Jae-Yong
    RESPIRATORY INVESTIGATION, 2019, 57 (06) : 544 - 551
  • [25] Updated Evaluation of the Safety, Efficacy and Tolerability of Pirfenidone in the Treatment of Idiopathic Pulmonary Fibrosis
    Gulati, Swati
    Luckhardt, Tracy R.
    DRUG HEALTHCARE AND PATIENT SAFETY, 2020, 12 : 85 - 94
  • [26] Comparative study between pirfenidone and traditional drugs in treatment of idiopathic pulmonary fibrosis
    Nafee, Ramadan M.
    Shoman, Waheed M.
    AboZaid, Mohammed M. N.
    El Wahed, Dalia A.
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2019, 68 (02): : 245 - 251
  • [27] Pirfenidone: significant treatment effects in idiopathic pulmonary fibrosis
    Hilberg, Ole
    Simonsen, Ulf
    du Bois, Roland
    Bendstrup, Elisabeth
    CLINICAL RESPIRATORY JOURNAL, 2012, 6 (03) : 131 - 143
  • [28] Pirfenidone in idiopathic pulmonary fibrosis: the CAPACITY program
    Richeldi, Luca
    du Bois, Roland M.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2011, 5 (04) : 473 - 481
  • [29] Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis
    Takeda, Yoshito
    Tsujino, Kazuyuki
    Kijima, Takashi
    Kumanogoh, Atsushi
    PATIENT PREFERENCE AND ADHERENCE, 2014, 8 : 361 - 370
  • [30] Pirfenidone for idiopathic pulmonary fibrosis: could it be a panacea?
    Antoniou, Katerina M.
    Bouros, Demosthenes
    PNEUMON, 2011, 24 (04) : 352 - 354